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1. Introduction 
Currently, anti-angiogenesis drugs are the popular treatment for cancer, which, however, 
are not without serious drawbacks. Virtually all such drugs are recombinant 
peptides/proteins or therapeutic antibodies and thus can only be administered via 
intravenous injection. In addition, these drugs tend to have low stability and short half life 
in vivo, which demands long treatment at high doses, which in turn renders the therapy 
expansive and could lead to high occurrences of side effects. Furthermore, these drugs 
usually target only one, out of many, step or pathway of angiogenesis and are not very 
effective. Even Avastin, the top-selling anti-tumor angiogenesis drug on the market, can 
only extend patients’ life span by 4~6 months without a cure. Therefore, it is necessary to 
develop efficacious, affordable, and orally available angiogenesis-inhibiting drugs.  
We report here the high-throughput screening (HTS) of over 500 Chinese medicinal herbs 
and plants in human vessel endothelial cell (HMEC-1) proliferation inhibition assay, which 
leads to the discovery of several candidate drugs with neovascularization inhibition 
property. Study on seropharmacology of several medicinal herbs/plants including albizia 
bark and Semen Vaccariae demonstrated their specific inhibition on HMEC-1 growth, 
suggesting their potential use as oral drugs for neovascularization inhibition. 
(seropharmacology as a new screen method to study Chinese medical effects in vitro, which 
cultive cells by medium containing a serum from animals of oral adminstrated a medicine. It 
is to be proved that the medicine has the effect after oral the medicine. And it paves a 
highway for investigation of traditional Chinese medicine. The standardized methodology 
of seropharmacology was initiaed to help to the exensive application of this technology.) 
Our study aims to investigate the efficacy and mechanism of such inhibition of albizia bark 
extracts, its effective moiety and effective monomer in multiple angiogenesis models. 
2. Reagents and methods 
2.1 Reagents  
MEM culture media was obtained from Gibco (City, Country). Sulforhodamine B (SRB) and 
bFGF were obtained from Sigma (St. Louis, MO, USA). FCS, trypsin, L-glutamine were 
purchased from Huamei Biological Company (Bejing, China). Anti- CD31 monoclonal 
antibody and immunohistochemisty kit were purchased from Zhongshan Jinqiao 
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Biotechnology Technical Service Co. Ltd. (Beijing, China). DAPI kit, TUNEL apoptosis kit, 
JC-1, Caspase-3, 9 spectrophotometry kit, mitotic cycle kit, and Annexin V-FITC apoptosis 
kit were obtained from Kaiji Biological Company (Nanjing, China). Cortex albiziae and 
licorice root were purchased from Shanhe Pharmaceutical Co. Ltd (Wuxi, China). 
2.2 Cell lines  
CPAE was kindly provided by Dr. J. Badet (Créteil University, Paris, France). Human 
microvascular endothelial cell line (HMEC-1) and human lung embryonic fibrocyte (MRC-
5) were generous gifts from Dr. He Lu (INSERM U553, National Institute for Health and 
Medicine Research, France). B16 melanoma, breast cancer cell (MCF-7) and Hepatocellular 
carcinoma (HepG2) were purchased from Institute, Chinese Academy of Sciences (Beijing, 
China). Cells are routinely maintained in MCDB complete culture medium in a 370C 
incubator with a humidified atmosphere containing 5% CO2. 
2.3 Animals  
Swiss nude mice and BALB/c mice were purchased from Shanghai Laboratory Animal 
Center, Chinese Academy of Sciences (Shanghai, China). Nude and C57bl/6 mice were used 
for human C51 colon cancer and mouse Lewis lung carcinoma ,respecctively,which were 
obtained from Tumor Research Center, Chinese Academy of Sciences (Beijing, China). 
Fertilized eggs were purchased from Mashan Poultry Center (Wuxi, China). 
2.4 Herbal extracts  
Albizia bark and licorice root were soaked in 5-volume of cold water for 2h, boiled for 30 
min, and strained. The remaining herbal material was returned to boil for 30 min in 3-
volume of water and strained. Both filtrates were combined and condensed in a waterbath 
to a concentrate of 1g of starting herbal material per mL. It totally get finished for 2 or 3 days 
2.5 Purification of active monomer  
Albizia bark extracts was loaded onto a D-101 resin column. About 70% of the ethanol elutes 
containing active ingredient were collected, as monitored by an in vitro activity assay. 
Further purification was carried out using standard silica gel column chromatography with 
a solvent system of chloroform–methanol–water for elution, antiphase styrene column 
chromatography, and antiphase C18 column chromatography to obtain the active ingredient 
at a purity of more than 90%. It is named julibroside J8, its constituents identified as 3-o-[ǃ-D-
xylopyranosyl-(1→2)-ǃ-D-fucopyranosyl-(1→6)-ǃ-D-gluCopyranosyl]-21-o-{(6s)-2-trans-2-
hydroxymethyl-6-methyl-6-o-[4-o-((6R)-2-trans-2,6-dimethyl-6-o-ǃ-D-quinovopyranosyl)-
2,7-octadienoyl)-ǃ-D-quinovopyranosyl]-2,7-octadienoyl}-acacicacid-28-o-ǃ-D-
glucopyranosyl-(1→3)-[ǂ-L-arabinofuranosyl-(1→4)]-ǂ-L-rhamnopyranosyl-(1→2)-ǃ-D-
glucopyranosyl ester (structure shown in Fig. 1). 
2.6 HMEC-1 cell proliferation inhibition assay  
HMEC-1 cells were seeded in 96-well plates at 7000 ~ 8000 cells per well and cultured for 24h 
and the volume of cell suspension in each plate is 150L. Following the addition of herbal 
extract with 150μL in each plate, cells were cultured for another 48h. Wells containing culture 
medium alone and those with untreated cells were served as blank and negative control, 
respectively. The experiment was carried out in quadruplicate and analyzed by SRB method.  
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Fig. 1. Chemical structure of compound j8. 
SRB assay was used to get the result of drug sensitivity assay of carcinoma. The effect of 
compound on proliferation inhibition was calculated according to the formula listed below: 
    
negative control signal test well signal
percentage inhibition %   100
negative control signal blank well signal
   
2.7 Chick chorioallantoic membrane (CAM) assay  
Fresh fertilized eggs (50 ± 5 g each) with intact shell were selected for the experiment. They 
were soaked in 0.1% benzalkonium bromide for 3 min, and then placed in an incubator 
maintained at 37.8 ± 0.5 0C with a relative humidity of 65% ~ 70%. The eggs were turned 
daily once in the morning and once in the evening and sorted into groups of 10, based on 
their embryonic age. Three treatment groups were dosed with albizia bark extract at 100, 500 
and 1000 μg/mL, whereas the negative control group were given normal saline only. 
Compounds were spotted onto sterile filter paper discs (4 mm x 4 mm) and air dried. The 
discs were subsequently placed onto the CAM between two vitelline veins through a 
window made in the eggshell and the window was sealed with sterile clear tape. Following 
an additional incubation for 2~3 days, seals were removed to expose the CAM; the blood 
vessels surround the disc (within a radius of 8mm) was counted and sorted into 3 categories 
based on their size; their vascular branching pattern and density were also noted. 
2.8 Matrigel plug assay [1-2]  
Eight-week-old female Swiss nude mice (18-22 g) were randomized into four groups (N=5 
per group) injected with 0.3ml Martrigel subcutaneously at ventral lateral side; an oral 
dosing regimen was followed and started on the same day. One group received albizia bark 
extract at 8mg/kg per day, while the other were given normal saline and served as control. 
Mice were sacrificed after seven consecutive days of daily dosing; Matrigel plugs were 
removed, fixed in ethanol, and embedded in paraffin. Immunohistochemistry was 
www.intechopen.com
 Tumor Angiogenesis 
 
70
performed on the sections for PECAM-1, a vessel endothelial cell marker, and blood vessels 
were counted on BX-40 optical microscope (Olympus, Japan). 
2.9 Pharmacodynamic analysis of Albizia bark extract in C51 nude mice model of 
colon cancer 
Fifteen nude mice (about 20g) were randomly assigned to three groups (N=5 per group) and 
inoculated subcutaneously with 5x107 of C51 colon cancer cells under right armpit. Daily 
oral dosing started 10 days after inoculation, when the size of tumor reached 8-10 mm3, and 
lasted for 4 weeks. The blank group received normal saline, control group licorice extract (8 
mg/kg), and treatment group albizia bark extract (8mg/kg). Mice were sacrificed by 
cervical dislocation on Day 28. A portion of tumor tissue was fixed in 4% formaldehyde, 
embedded in paraffin and sectioned, sectioned into a thickness of 5µ m, and then stained 
with. Immunohistochemistry was performed on the sections for PECAM-1, blood vessels 
counted on BX-40 optical microscope (Olympus, Japan) with an overall magnification of 
200x, and microvascular density (MVD) determined as previously described. It has been 
done for two weeks. 
2.10 Pharmacodynamic analysis of albizia bark extract in nude mice model of lung 
cancer metastasis  
Seven-week-old female C57BL/6 mice (18-20g) were randomized into three groups (N = 8~10 
per group) and inoculated with 0.2ml of Lewis lung cancer (LLC) cell suspension (5x106/L) by 
ventral subcutaneous injection. Seven days later, treatment group were administered albizia 
bark ingredients or licorice by gavage daily, whereas control group received normal saline. 
Mice were sacrificed after 15 days. Lungs were fixed , in 4% formaldehyde and embedded in 
paraffin and sectioned for H&E staining. Three nonconsecutive sections from each sample 
were analyzed to determine the mean numbleof lung metastases.  
2.11 Cell migration assay using scratch wound healing[3]  
HMEC-1 cells were seeded in 24-well plate at 8x104 cells per well, respectively, and 
incubated for 24h to allow attachment. A scratch of 1mm in width was introduced at the 
center of each well by drawing a plastic pipette tip across the surface of cell monolayer and 
detached cells were washed off with PBS. Media containing drugs at various concentrations 
were then added to each well and cells were photographed immediately with a 100x 
magnification and the resulting image was defined as the migration map at 0h. 
Subsequently, cells were photographed in the same visual field at 6h, 12h, 24h, and 48h 
respectively. Images obtained were processed with software IPWin60C and the distance 
between two opposing wound margins was measured. Cell mobility was calculated based 
on 6 measurements taken at randomly selected sites per image.  
2.12 Tube formation assay[4]  
Matrigel was thawed at 40C O/N and added to 24-well plates that had been pre-chilled on 
ice at 150 l per well. The plates were placed in a 370C / 5% CO2 incubator for 30 min. 3B11 
cell suspension (4x105 cells/ml) was mixed with equal volume of cell culture media 
containing different concentrations of drugs and a total volume of 200 l was plated in each 
well of a Matrigel plate. Cells were incubated in a 370C / 5% CO2 incubator for 12h and 
photographed periodically. 
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2.13 H&E staining  
HMEC-1 single cell suspension was add to a 6-well plate at 104 or 105 per well and cultured 
on glass coverslips for 24h, followed by further culture of 48h in the presence of drugs at 
various concentration. After decanting culture media, coverslips were washed three times 
with PBS, fixed with formalin for 10 min, and stained with hematoxylin and eosin. 10 
Kunming mice (20-22g) were administered J8 for 10 days, mice were sacrificed. Lungs liver, 
and kidney were fixed, embedded in paraffin and sectioned for H&E staining. The change in 
cell morphology was observed under the microscope. 
2.14 DAPI staining  
HMEC-1 cells in logarithmic phase were plated in tissue culture dish and cultured on 
glass coverslip for 24h to allow adhesion. Julibroside J8 was added to a final concentration 
of 0.5, 1.0, and 2.5 μg / mL, while the control received no compound, and cells were 
cultured for another 24h. Coverslips were washed in PBS followed by DAPI staining 
buffer, stained in DAPI working solution at 370C for 15 min, rinsed in methanol and 
mounted in glycerol. The nuclear staining was examined on a fluorescence microscope 
with an oil-immersion lens.  
2.15 TUNEL assay  
HMEC-1 cells in logarithmic phase were plated in tissue culture dish and cultured on glass 
coverslips for 24h. Julibroside J8 was added to a final concentration of 0.5, 1.0, and 2.5 μg / 
mL, while the control received no compound, and cells were cultured for another 24h. 
Coverslips were fixed in freshly prepared 4% paraformaldehyde (PFA) at RT for 15 min ~1h. 
blocked in 3% H2O2 /MeOH at RT for 10 min, and permeabilized in freshly prepared 0.1% 
Triton X-100 / 0.1% sodium citrate on ice for 2 minutes. Washed samples were incubated 
with 50 μL fresh TdT reaction mix in the dark for 60 minutes at 370C in a humidified 
chamber. Negative controls were incubated with TdT reaction mix without TdT enzyme. 
Samples were washed in PBS three times and incubated with 50 μL Streptavidin-HRP 
solution in the dark for 30 minutes at 370C in a humidified chamber. Fresh DAB solution 
was applied to washed coverslips for 10 minutes at RT, which were subsequently rinsed, 
counterstained with hematoxylin and mounted.  
2.16 Detection of cell death and apoptosis by flow cytometry (FCM)  
HMEC-1 cells in logarithmic growth phase were inoculated into cell culture flask at 5ｘ105 
cell/ml in MCDB complete medium for 24h. Julibroside J8 was added to a final concentration 
of 0.5~2.5 μg/ml and cells were cultured for another 48h. The blank control received 
no compound. Cells were trypsinized, washed three times with PBS, and resuspended in 
200μL binding buffer. 10 μL Annexin V-FITC was added into the cell suspension and 
incubated at RT protected from light for 30 min, followed by the addition of 5μL propidium 
iodide (PI) and continued incubation for another 5 min. With the addition of 400μL Binding 
buffer working solution, cells were ready for FCM. 
2.17 Analysis of cell cycle and DNA content by FCM  
HMEC-1 cells in logarithmic growth phase were inoculated into cell culture flask at 5ｘ105 
cell/ml in MCDB complete medium for 24h. Julibroside J8 was added to a final concentration 
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of 0.5~2.5 μg/ml and cells were further cultured for 48h. The blank control received 
no compound. Cells were trypsinized, washed twice with PBS, and resuspended in 500 μL 
PBS. While gently mixing, 1.5 mL of cold 70% EtOH in PBS (pre-chilled at -200C) were 
added into cell suspension dropwise and the mixture was placed in the refrigerator for at 
least 24h. Prior to FCM analysis, cells were washed twice with PBS, resuspended in 1ml PI 
staining solution (PI at 100 g/ml in PBS with 100 g /ml DNase-free RNase A) and 
incubated at 40C for 30 min protected from light. The stained cells were washed in PBS, then 
resuspended in up to 1 ml of PBS, and strained through a 200 mesh screen. The cells were 
put through FCM; data from 5,000-10,000 cells per sample were analyzed using software 
Cellfit (BD Biosciences, USA). 
2.18 Analysis of mitochondrial membrane potential by FCM  
HMEC-1 cells in logarithmic growth phase were inoculated into cell culture flask at 5ｘ105 
cell/ml in MCDB complete medium for 24h. Julibroside J8 was added to a final concentration 
of 0.5~2.5 μg/ml and cells were cultured for another 24h. The blank control received 
no compound. Cells were trypsinized and washed twice with PBS. No more than 106 cells 
were collected and resuspended in 500 ul lipophilic cation 5,5',6,6'-tetrachloro-1,1',3,3'-
tetraethylbenzimidazolcarbocyanine iodide (JC-1) staining solution. JC-1 is more 
advantageous over rhodamines and other carbocyanines, capable of entering selectively into 
mitochondria, since it changes reversibly its color from green to orange as membrane 
potentials increase (over values of about 80-100 mV). This property is due to the reversible 
formation of JC-1 aggregates upon membrane polarization that causes shifts in emitted light 
from 530 nm (i.e., emission of JC-1 monomeric form) to 590 nm (i.e., emission of J-aggregate) 
when excited at 490 nm; the color of the dye changes reversibly from green to greenish 
orange as the mitochondrial membrane becomes more polarized. Both colors can be 
detected using the filters commonly mounted in all flow cytometers, so that green emission 
can be analyzed in fluorescence channel 1 (FL1) and greenish orange emission in channel 2 
(FL2), subsequently incubated in a CO2 incubator at 370C for 15 ~ 20 min. Cells were then 
pelleted at RT (2000 rpm, 5 min) and washed twice with incubation buffer. Finally, cells 
were resuspended in 500 ul of incubation buffer and ready for FCM. 
2.19 Determination of Caspase-3, 9 content in endothelial cells by spectrophotometer 
HMEC-1 cells of logarithmic growth phase were seeded in cell culture flasks at 5×105 
cell/mL. After 24h, julibroside J8 was added to a final concentration of 1.5 μg /mL. Cells were 
harvested at 4, 8 and 12 hours after drug treatment and 5×106 cells were collected at each 
time point. Cells were washed twice with PBS. After the 2nd wash, cells were centrifuged at 
2000 rpm for 5 min and the supernatant was discarded. 150 μL of ice-cold Lysis Buffer was 
used to resuspend the cell pellet; the resulting cell extraction was placed on ice for 20 ~ 60 
min, with 3 ~ 4 short vortexes (10 sec each time) in between. The extraction was centrifuged 
at 4℃ (10,000 rpm, 1min) and the supernatant, or the lysate, was carefully transferred to a 
fresh eppendorf (EP )tube and stored on ice. 50 μL of cell lysate was used for caspase-3 and 
caspase-9 enzyme activity measurement with caspase-3 and caspase-9 activity assay kits by 
spectrophotometry. Meanwhile, the protein concentration was determined by Bradford 
assay to normalize caspase activity by mg of protein. All assays were performed according 
to manufactures’ instructions. 
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3. Results 
3.1 Albizia bark extracts on neovascularization 
3.1.1 Albizia bark extracts inhibit neovascularization in CAM assay 
CAM assay is one of several classical in vivo models for studying angiogenesis. We found 
here that CAM treated with normal saline showed prominent angiogenesis. A large number 
of vessels radiated from underneath the control disc and were highly branched, which led to 
abundant capillaries that are responsible for the vibrant color of the CAM (Fig. 2, left 
panels). However, the number of vessels radiating from disc treated with albizia at 500 
ug/mL was greatly reduced, and the vessels were sparse, disorganized, with a light yellow 
appearance (Fig. 2, right panels). The effect was dose-dependent and the phenotype was 
more pronounced with increased albiziae at 1000 ug/mL (Table 1), suggesting that albizia 
extract is an inhibitor of neovascularization.  
 
 
A and C: control with normal saline, B and D: albiziae treatment. 
Fig. 2. Effect of Albizia julibrissin extracts on neovascularization in CAM (top, 10x; bottom, 20x). 
 
albiziae extract  
(µg/mL) 
No. of blood vessel 
Large Medium Small 
0 (control) 2.5±0.20 3.5±0.67 19.7±0.47 
100 2.1±0.34 3.9±0.53 15.6±0.29 
500 2.6±0.54 2.8±0.97 10.7±0.19* 
1000 2.5±0.67 2.5±0.27 6.8±0.48 ** 
* P<0.05, **P<0.01 vs Control 
Table 1. Effect of Albizia julibrissin extracts on neovascularization in CAM (.x ±s , n =10) 
A B 
C D 
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3.1.2 Albizia bark extracts inhibit vascularization in bFGF-induced Matrigel plugs 
Paraffin sections were obtained from implanted Matrigel plugs and stained for endothelial 
marker CD31 (Fig. 3A, as shown in brown). bFGF to induce substantial microvasculature 
formation in Matrigel plugs, as evidenced by the presence of abundant endothelial cells 
which were positively stained for CD31. Treatment with albizia extract decreased the 
amount of endothelial cells in bFGF-induced Matrigel plugs, suggesting an inhibition of 
microvasculature formation, while treatment with licorice extract had no discernable effect 
on angiogenesis. Plugs from uninduced Matrigel were rarely populated by endothelial cells.  
 
 
 
  A:  -bFGF (Blank)          B:  +bFGF 
  C:  +bFGF / licorice  D:  +bFGF/ albizia 
Fig. 3. Effect of Albizia julibrissin extracts on angiogenesis in matrigel plug (100x). 
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3.1.3 Albizia bark extracts inhibit neovascularization in C51 colon cancer mouse 
model 
Nude mice inoculated with C51 colon cancer cells developed tumor, which contained in 
blood vessels. Compared to control group that were administered with saline, albiziae 
treatment caused a 67.5% reduction in tumor growth, while licorice extract showed only a 
slight inhibition rate (IR)f 10% (Table 2). IHC of endothelial marker CD31 on tumor tissue 
sections revealed extensive vessel formation in control group (Fig. 4). Microvessel density 
(MVD) was measured with a light microscope in a single area of invasive tumor (200x field 
or 0.74 mm2) representative of the highest microvessel density (neovascular "hot spot"). This 
was done after endothelial cells, lining the microvessels, had been highlighted with anti-
factor VIII-related antigen/von Willebrand's factor (F8RA/vWF). Subsequent studies by 
other investigators, using either anti-F8RA/vWF or other relatively vessel-specific reagents 
such as anti-CD31. MVD was drastically reduced in albiziae-treated tumors, demonstrating 
that albiziae is a potent inhibitor of tumor neovascularization. Despite of its mild inhibition 
on tumor growth, licorice extract did not seem to have much effect on neovascularization, 
and there were no statistically significant differences between the control and licorice-
treated groups. 
      
negative control volume test well volume
The rate of inhibition IR  %   100
negative control volume 
   
 
CD3 
  
 A:  control B:  licorice extract C:  alzabiae extract 
                             
 
Fig. 4. Albizia julibrissin extracts reduced microvessel density in tumor. 
 
 
Group No. of mice IR (%) MVD 
Blank 5 0 31.6±2.89 
Licorice 5 10 29.1±1.78 
albiziae 5 67.5 10.5±0.98 * 
* P <0.05. vs Control 
 
Table 2. The rate of inhibition (IR) of tumor growth and microvessel density (MVD) of 
different groups. 
A B C
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3.1.4 Albiziae extract inhibits metastasis in mouse LLC model 
Nude mice were inoculated with LLC cells and their lungs harvested and examined for the 
appearance of tumor as sign of metastasis. Five out of 10 mice in saline control group 
developed lung cancer with large nodules, the average size of tumor at 4.5±6.6 mm3; the 
tumor cells were variable in size, sometimes with giant cancer cells. The nodules appeared 
highly invasive and with abundant interstitial vessels (Fig. 5A). Normal lung tissues were 
compressed and damaged, and infiltrated by large number of inflammatory cells. The 
histopathology of tumor in licorice extract group showed no marked difference from saline 
group (Fig. 5B). Albiziae bark extracts, on the other hand, significantly improved and 
stabilized the cancer. Compared to the 50% metastasis rate in control group, only 1 in 8 mice 
from albiziae extracts group developed lung cancer, with an average size of 0.5±1.4 mm3. 
The nodule showed much reduced cell nuclear division and interstitial vasculature. No 
substantial infiltration by inflammatory cells was discovered. The combined results showed 
clear inhibition of LCC metastasis by albiziae extracts. 
 
 
 
 
 
A:  negative control B:  licorice extracts C:  albizia extracts 
 
 
          
Fig. 5. Antitumor effect of Albizia julibrissin extracts in mice implanted with LLC. 
3.2 The effect of albiziae effective monomer julibroside J8 on neovascularization 
3.2.1 Julibroside J8 readily inhibits HMEC-1 cell proliferation 
In order to identify the specificity of anti-angiogenic of Julibroside J8 in vitro，We first 
investigated the effect of Julibroside J8 (1μg/ml,2μg/ml,5μg/ml,10μg/ml,20μg/ml) on 
proliferation of B16, MCF-7, hepG2, MRC-5 and HMEC-1. The results indicated that 
Julibroside J8 caused a decrease in proliferation of B16, MCF-7, hepG2 and HMEC-1. The IC50 
was estimated to be 10μg/ml, 9.5μg/ml, 8.8μg/ml and 1.2μg/ml, respectively. But it did not 
significantly inhibit proliferation of normal cell (MRC-5) at the concentration of 20μg/ml. 
Another experiment in mice proved that julibroside J8 had little effects on the quiescent 
vessels of kidney, lung, and liver.(Fig 6). The results show that J8 has specific action on anti-
angiogenic in vitro and in vivo. 
C B A 
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Fig. 6. No significant effect of julibroside J8 on the quiescent vessels. 10 
3.2.2 julibroside J8 inhibits Matrigel tube formation in vitro 
As shown in Fig. 6, julibroside J8 Demonstrated dose-dependent inhibition in Matrigel tube 
formation assay (Fig. 7). At 1 µg/mL of julibroside J8, the number of tube formed was 
reduced. At 2.0 µg/mL, HMEC-1 cells showed limited mobility and formed few tubes. At 
4.0 µg/mL, HMEC-1 cells had difficulty attaching.  
A (lung) 
 
B (liver) 
 
C (kidney) 
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     A (control)                                                     B (J8 treatment) 
 
 
Fig. 7. Effect of julibroside J8 on tube formation of HMEC-1. 
3.2.3 julibroside J8 inhibits microvessel formation in CAM assay 
Compared to the microvessels formed in saline control group, the ones in julibroside J8 
treatment group were abnormal in appearance and sparsely distributed (Fig. 7) and the 
number of blood vessel in all three size categories (L, M, S) were reduced (Table 3) in a dose-
dependent manner, demonstrating a clear inhibition of neovascularization by julibroside J8. 
 
 
 
julibroside J8 (µg/mL) 
No. of blood vessels 
Large Medium Small 
0 (control) 2.8±0.20 4.5±0.87 21.8±1.89 
10  2.1±0.34 3.8±0.36 16.6±0.65 
50  2.6±0.54 2.8±0.97 9.9±0.30 * 
100  2.3±0.67 2.5±0.27 4.9±0.57 ** 
* P<0.05, **P<0.01 vs Control 
 
Table 3. Effect of julibroside J8 on neovascularization in CAM (.x ±s , n =10). 
3.2.4 julibroside J8 arrests cell cycle at G2/M phase 
FCM cell cycle analysis of HMEC-1 cells treated with julibroside J8 at various concentrations 
for 48 hrs showed a dose-dependent reduction of dividing cells (Table 4 and Fig. 8). At 0.5, 
1.5 and 2.5 µg/mL of julibroside J8, the percentage of cells in S phase was decreased to 
30.20%, 14.43% and 11.25%, respectively, compared to 38.92% in the control group. In the 
mean time, increased number of cells was found in G2/M and sub G1 phases, while the 
number of cells in G1 phase remained constant.  
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Cell Cycle 
julibroside J8 (µg/mL) 
0 0.5 1.5 2.5 
S 38.92% 30.20% 14.43% 11.25% 
G2/M 8.66% 21.35% 29.15% 30.25% 
G1 52.42% 48.43% 56.47% 54.2% 
Sub G1 0% 7.11% 15.85% 16.49% 
Table 4. Cell cycle analysis of HMEC-1 cells treated with julibroside J8. 
 
 
control julibroside J8 (0.5 µg/mL) 
 
julibroside J8 (1.5 µg/mL) julibroside J8 (2.5 µg/mL) 
Fig. 8. Effects on cell cycle and apoptosis of HMEC-1 after treated with different 
concentration julibroside J8.for 48h. 
3.3 Effect of julibroside J8 on apoptosis and its mechanism 
3.3.1 Observation of nuclear structure by DAPI staining 
HMCE-1 cells cultured on coverslips were stained with DAPI and their nuclear morphology 
was observed by fluorescent microscopy (Fig. 9). Control group in general showed weaker 
fluorescence, which was enhanced upon fixation. The nuclei appeared round, clear-edged, 
and uniformly stained. HMCE-1 cells treated with julibroside J8 exhibited a stronger blue 
stain and displayed many characteristics associated with apoptotic cells, such as irregular 
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edges around the nucleus, chromosome concentration in the nucleus, heavier coloring, and, 
with nuclear pyknosis, an increased number of nuclear body fragments.  
 
  
control (40) julibroside J8 (2.0 ug/ml) (40) 
Fig. 9. The morphological change of HMEC-1 cells by DAPI. 
3.3.2 Determination of DNA fragmentation by TUNEL assay  
HMEC-1 cells grown on coverslips were stained for terminal deoxynucleotidyl transferase 
activity, an indication of DNA fragmentation and hallmark of late stage apoptosis. The 
reaction was developed with DAB chromogen and images examined by light microscopy 
(Fig. 10). Few nuclei were stained dark brown in untreated cells, whereas an increase of 
stained nuclei was detected in julibroside J8-treated HMEC-1 cells in a dose-dependent 
manner, indicating julibroside J8 is able to induce apoptosis. 
3.3.3 FCM analysis of Annexin V/ PI double labeling 
Annexin V/PI double staining coupled with FAM analysis allows the distinguishing of live 
cells (Annexin V neg, PI neg), early apoptotic cells (Annexin V pos, PI neg), and late apoptotic 
cells (Annexin V pos, PI pos). It was discovered that under treatment of increasing 
concentration of julibroside J8 for 48 hr, increased cell number appeared in the two right 
quadrants of the histogram which was indicative of early and late apoptotic events. 
Compared to the combined apoptotic rate of 8.34% in the control group, julibroside J8 
treatment at 0.5, 1.5 and 2.5 µg/mL resulted in an significantly higher apoptotic rate of 
13.63%, 19.55% and 32.32%, respectively (Table 5). 
 
Julibroside J8 
(g/mL)  
HMEC-1(%) 
Live 
cells 
Early apoptotic 
cells 
Late apoptotic 
cells 
Dead 
cells 
0 90.81 5.15 3.19 0.86 
0.5  82.91 8.14 7.79 1.16 
1.5  78.15 7.65 11.90 2.28 
2.5  67.96 8.94 21.38 1.72 
Table 5. Effects of julibroside J8 on necrosis and apoptosis rate in HMEC-1 cells. 
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control 
 
julibroside J8 (0.5 μg/mL) 
 
julibroside J8 (1.5 μg/mL) 
 
julibroside J8 (2.5 μg/mL) 
Fig. 10. Effect of julibroside J8 on DNA fragmentation in HMEC-1 cells (400x). 
3.3.4 julibroside J8 does not affect mitochondrial membrane potential (m) 
As shown in Fig. 12, treatment with increasing dose of julibroside J8 did not result in change 
in HMEC-1 m accordingly, and there were no statistically significant differences between 
treated groups and control group, indicating that m is not involved in HMEC-1 cell 
apoptosis induced by julibroside J8.  
3.3.5 Effect of julibroside J8 on Caspase-3, 9 of HMEC-1  
As demonstrated in Table 6, treatment with julibroside J8 did not change the activities of 
Caspase-3, 9, suggesting julibroside J8-induced apoptosis is unrelated to Caspase-3, 9.  
 
 
lysis+reaction 
buffer 
blank 
negative 
control 
4 h 10 h 24 h 
Caspase-3 0.053 0.063 0.231 0.258 0.234 0.214 
Caspase-9 0.053 0.060 0.219 0.229 0.203 0.199 
Table 6. The effect of julibroside J8 (2 µg/mL) on Caspase-3, 9 activities in HMEC-1 cell. 
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control 
 
 
julibroside J8 (0.5 μg/mL) julibroside J8 (1.0 μg/mL) 
 
 
julibroside J8 (1.5 µg/mL) 
 
julibroside J8 (2.5 µg/mL) 
Fig. 11. Effect of julibroside J8 on ΔΨm in HMEC-1 cells after incubation for 24 h. 
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4. Discussion 
Invasiveness, metastasis and hyperproliferation are the key issues in tumor cell biology. 
Since Folkman proposed the concept of angiogeneis in 1972, tumor neovascularization has 
attracted much interest from the field of biological medicine and pharmaceutical industry, 
and been applied to the research and development of novel anticancer drugs, namely 
angiogenesis inhibitors targeting vessel endothelial cells to block the blood and nutrient 
supply to tumor and thus its growth and metastasis[5-6]. Using HMEC-1 cell proliferation 
inhibition assay as HTS read-out, our study identified 4, out of 500, medicinal herbs that 
function as neovascularization inhibitors, and among which albizia bark extract was shown 
to be able to inhibit tumor neovascularization and metastasis by in vitro and in vivo assays. 
Monitored by HMEC-1 proliferation inhibition assay, we obtained effective monomer 
julibroside J8 through a series of separation and purification steps. In vitro cell-based assay 
determined the IC50 of julibroside J8 on HMEC-1 proliferation as 1.2 μg/mL. Julibroside J8 can 
also inhibit Matrigel tube formation in vitro and neovascularization in CAM assay. 
Our results showed that julibroside J8 treatment changed cell cycle distribution, resulting in 
more cells at G2/M phase and less at S phase, and the appearance of sub-G1 peak of apoptosis, 
which demonstrate that julibroside J8 is capable of cell proliferation inhibition and induction of 
apoptosis. Similarly, apoptosis was detected by Annexin V-FITC/PI double labeling. 
Apoptosis is a cellular response to certain environmental messages and thus regulated by 
various endogenous and exogenous factors. Mitochondria are a vital cell organelle whose 
main function is energy conversion. In addition, mitochondria are involved in a range of 
other processes, such as signaling, cellular differentiation, cell death, as well as the control of 
the cell cycle and cell growth. A large body of work has established the involvement of 
mitochondria in apoptosis, and alterations in m has been regarded as one of the earliest 
events in cell death, prior to the appearance of such hallmarks as chromatin condensation 
and DNA fragmentation. Once m collapses, apoptosis becomes irreversible. Our study 
showed that julibroside J8 treatment leads to the decrease in HMEC-1 cell number. DAPI 
stain illustrated cell shrinkage, membrane blebbing and increasing cellular debris when cells 
were treated with high concentration of julibroside J8. In addition, DNA fragmentation was 
identified by TUNEL Apoptosis assay. FCM analysis revealed that cells were arrested at 
G2/M phase of the cell cycle following julibroside J8, accompanied by a sizable peak of 
apoptosis. Further analysis by Annexin-V/PI double labeling proved the dose-dependent 
effect of julibroside J8 on apoptosis. However, ΔΨm did not seem to be affected.  
Members of caspase family play a vital role in mitochondria-mediated apoptosis; the key 
players among them are caspase-3 and 9. Both are present in cytosol under normal 
physiological conditions as inactive precursors. When cellular stress (eg. DNA damage) 
occurs, procaspase-9 is activated by cytochrome c released from mitochondria; the resulting 
caspase-9 in turn activates the downstream procaspase-3. The activated caspase-3, a key 
factor in apoptosis execution, cleaves a host of downstream substrate and cell undergoes 
apoptosis. However, our study did not detect the change in caspase-3/9 acitivity as a 
function of time, suggesting julibroside J8 induces apoptosis in HMCE-1 cells in mechanism 
independent of mitochondria pathway. 
In all, we conclude that julibroside J8, a novel molecule purified from albizia bark extracts, is 
able to inhibit HMEC-1 cell proliferation by cell cycle arrest at G2/M phase. In addition, we 
proved by multiple means that julibroside J8 can induce apoptosis. However, julibroside J8 
does not seem to affect ΔΨM nor caspase-3/9 activity, suggesting a mitochondria-
independent apoptosis pathway. 
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